Denosumab is the monoclonal antibody that inhibits RANK - ligand
D
RANK-L inhibits osteoclasts and inhibits osteoporosis
High-Yield Explanation
RANK - L acts on RANK - receptors presents on osteoclasts and activates them and stimulates bone resorption. Denosumab inhibits RANK - Ligand and prevent bone resorption.